Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Amortization of Deferred Charges (2016)

ENDRA Life Sciences (NDRA) has disclosed Amortization of Deferred Charges for 1 consecutive years, with $338164.0 as the latest value for Q4 2016.

  • Quarterly Amortization of Deferred Charges changed N/A to $338164.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $684283.0 through Dec 2017, changed N/A year-over-year, with the annual reading at $232426.0 for FY2020, 90.13% down from the prior year.
  • Amortization of Deferred Charges for Q4 2016 was $338164.0 at ENDRA Life Sciences, down from $346119.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $346119.0 in Q3 2016, with the low at $338164.0 in Q4 2016.